Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Scientific Reports|November 13, 2019
Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cellsMaría G Cortiguera, Lorena García-Gaipo, Simon D Wagner, et al.
Haematologica|February 6, 2014
B-cell lymphoma mutations: improving diagnostics and enabling targeted therapiesJosé P Vaqué, Nerea Martínez, Ana Batlle-López, et al.
European Journal of Internal Medicine|December 3, 2023
Features of immune mediated diseases in JAK2 (V617F)-positive myeloproliferative neoplasms and the potential therapeutic role of JAK inhibitorsCarmen Álvarez-Reguera, Diana Prieto-Peña, Alba Herrero-Morant, et al.
Thrombosis Research|September 23, 2014
Inherited ADAMTS13 deficiency (Upshaw-Schulman syndrome): a short reviewAlmudena Pérez-Rodríguez, Esther Lourés, Ángela Rodríguez-Trillo, et al.
Biomolecules|May 4, 2026
CTCF Regulates Erythroid Differentiation Through Control of Core Erythroid Transcription FactorsLorena García-Gaipo, Vanessa Junco, Lucía García-Gutiérrez, et al.
Oncotarget|July 23, 2014
High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycleJuan M Caraballo, Juan C Acosta, Miguel A Cortés, et al.
Journal of Clinical Medicine|September 4, 2020
Portal Thrombosis in Cirrhosis: Role of Thrombophilic DisordersJosé Ignacio Fortea, Inés García Carrera, Ángela Puente, et al.
Vaccines|December 28, 2021
COVID-19 mRNA Based Vaccine Immune-Response Assessment in Nursing Home Residents for Public Health DecisionDavid San Segundo, Alejandra Comins-Boo, Patricia Lamadrid-Perojo, et al.
Cancer Medicine|January 25, 2021
R-COMP versus R-CHOP as first-line therapy for diffuse large B-cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO groupJuan-Manuel Sancho, Rubén Fernández-Alvarez, Francisco Gual-Capllonch, et al.
Oncotarget|February 25, 2016
Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible markerAna Batlle-López, Sonia González de Villambrosía, Mazorra Francisco, et al.
Pageof 2